EJP RD is co-organising a series of 3 workshops dedicated to drug repurposing for rare disease. Registration links will be provided soon. Registration is free but places are limited.
This first session, which will be held on October 21st, is entitled “An introduction to drug repurposing for rare diseases – the benefits, the process and the development scenarios”
The parts 2 and 3 are planned for:
- 28 October 2021 (1500-1700 CEST): Towards commercialization of a repurposed drug – intellectual property, patenting strategies, access to data, active ingredients, and collaborations between academia and industry for drug repurposing
- 4 November 2021 (1500-1700 CET): Getting a repurposed drug the to the patient – regulatory processes, reimbursement and prescription scenarios for repurposed drugs
Each 2-hour workshop will feature expert speakers sharing their experiences in the drug repurposing process on the basis of case studies, as well as an interactive Q&A session. The goal is to highlight the processes involved in each of the scenarios in drug repurposing, understand the main challenges and hear about solutions from the field.
This 3-part workshop is for academic researchers and research funders, policymakers and industry scientists interested in drug repurposing.
